Gisela G Slaats1, Christine R Isabella2, Hester Y Kroes3, Jennifer C Dempsey2, Hendrik Gremmels1, Glen R Monroe3, Ian G Phelps2, Karen J Duran3, Jonathan Adkins4, Sairam A Kumar2, Dana M Knutzen2, Nine V Knoers3, Nancy J Mendelsohn5, David Neubauer6, Sotiria D Mastroyianni7, Julie Vogt8, Lisa Worgan9, Natalya Karp10, Sarah Bowdin11, Ian A Glass2, Melissa A Parisi12, Edgar A Otto13, Colin A Johnson14, Friedhelm Hildebrandt15, Gijs van Haaften3, Rachel H Giles1, Dan Doherty16. 1. Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Department of Pediatrics, University of Washington, Seattle, Washington, USA. 3. Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Department of Pediatrics, University of Washington, Seattle, Washington, USA Division of Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, Arizona, USA. 5. Department of Medical Genetics, Children's Hospitals & Clinics of Minnesota, Minneapolis, Minnesota, USA. 6. Department of Child, Adolescent and Developmental Neurology, University Children's Hospital Ljubljana, Ljubljana, Slovenia. 7. Department of Neurology, Children's Hospital of Athens "P. and A. Kyriakou", Athens, Greece. 8. West Midlands Regional Genetics Service, Birmingham Women's Hospital, Birmingham, UK. 9. Department of Clinical Genetics, Liverpool Hospital, Liverpool, Australia. 10. Medical Genetics Program, Department of Pediatrics, London Health Science Centre, University of Western Ontario, London, Ontario, Canada. 11. Division of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. 12. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA. 13. Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA. 14. Section of Ophthalmology and Neuroscience, Leeds Institutes of Molecular Medicine, University of Leeds, Leeds, UK. 15. Division of Nephrology, Boston Children's Hospital, Boston, Massachusetts, USA Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. 16. Department of Pediatrics, University of Washington, Seattle, Washington, USA Seattle Children's Research Institute, Seattle, Washington, USA.
Abstract
BACKGROUND: Joubert syndrome (JS) is a recessive ciliopathy characterised by a distinctive brain malformation 'the molar tooth sign'. Mutations in >27 genes cause JS, and mutations in 12 of these genes also cause Meckel-Gruber syndrome (MKS). The goals of this work are to describe the clinical features of MKS1-related JS and determine whether disease causing MKS1 mutations affect cellular phenotypes such as cilium number, length and protein content as potential mechanisms underlying JS. METHODS: We measured cilium number, length and protein content (ARL13B and INPP5E) by immunofluorescence in fibroblasts from individuals with MKS1-related JS and in a three-dimensional (3D) spheroid rescue assay to test the effects of disease-related MKS1 mutations. RESULTS: We report MKS1 mutations (eight of them previously unreported) in nine individuals with JS. A minority of the individuals with MKS1-related JS have MKS features. In contrast to the truncating mutations associated with MKS, all of the individuals with MKS1-related JS carry ≥ 1 non-truncating mutation. Fibroblasts from individuals with MKS1-related JS make normal or fewer cilia than control fibroblasts, their cilia are more variable in length than controls, and show decreased ciliary ARL13B and INPP5E. Additionally, MKS1 mutant alleles have similar effects in 3D spheroids. CONCLUSIONS: MKS1 functions in the transition zone at the base of the cilium to regulate ciliary INPP5E content, through an ARL13B-dependent mechanism. Mutations in INPP5E also cause JS, so our findings in patient fibroblasts support the notion that loss of INPP5E function, due to either mutation or mislocalisation, is a key mechanism underlying JS, downstream of MKS1 and ARL13B. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND:Joubert syndrome (JS) is a recessive ciliopathy characterised by a distinctive brain malformation 'the molar tooth sign'. Mutations in >27 genes cause JS, and mutations in 12 of these genes also cause Meckel-Gruber syndrome (MKS). The goals of this work are to describe the clinical features of MKS1-related JS and determine whether disease causing MKS1 mutations affect cellular phenotypes such as cilium number, length and protein content as potential mechanisms underlying JS. METHODS: We measured cilium number, length and protein content (ARL13B and INPP5E) by immunofluorescence in fibroblasts from individuals with MKS1-related JS and in a three-dimensional (3D) spheroid rescue assay to test the effects of disease-related MKS1 mutations. RESULTS: We report MKS1 mutations (eight of them previously unreported) in nine individuals with JS. A minority of the individuals with MKS1-related JS have MKS features. In contrast to the truncating mutations associated with MKS, all of the individuals with MKS1-related JS carry ≥ 1 non-truncating mutation. Fibroblasts from individuals with MKS1-related JS make normal or fewer cilia than control fibroblasts, their cilia are more variable in length than controls, and show decreased ciliary ARL13B and INPP5E. Additionally, MKS1 mutant alleles have similar effects in 3D spheroids. CONCLUSIONS:MKS1 functions in the transition zone at the base of the cilium to regulate ciliary INPP5E content, through an ARL13B-dependent mechanism. Mutations in INPP5E also cause JS, so our findings in patient fibroblasts support the notion that loss of INPP5E function, due to either mutation or mislocalisation, is a key mechanism underlying JS, downstream of MKS1 and ARL13B. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Liyun Sang; Julie J Miller; Kevin C Corbit; Rachel H Giles; Matthew J Brauer; Edgar A Otto; Lisa M Baye; Xiaohui Wen; Suzie J Scales; Mandy Kwong; Erik G Huntzicker; Mindan K Sfakianos; Wendy Sandoval; J Fernando Bazan; Priya Kulkarni; Francesc R Garcia-Gonzalo; Allen D Seol; John F O'Toole; Susanne Held; Heiko M Reutter; William S Lane; Muhammad Arshad Rafiq; Abdul Noor; Muhammad Ansar; Akella Radha Rama Devi; Val C Sheffield; Diane C Slusarski; John B Vincent; Daniel A Doherty; Friedhelm Hildebrandt; Jeremy F Reiter; Peter K Jackson Journal: Cell Date: 2011-05-13 Impact factor: 41.582
Authors: Enza Maria Valente; Clare V Logan; Soumaya Mougou-Zerelli; Jeong Ho Lee; Jennifer L Silhavy; Francesco Brancati; Miriam Iannicelli; Lorena Travaglini; Sveva Romani; Barbara Illi; Matthew Adams; Katarzyna Szymanska; Annalisa Mazzotta; Ji Eun Lee; Jerlyn C Tolentino; Dominika Swistun; Carmelo D Salpietro; Carmelo Fede; Stacey Gabriel; Carsten Russ; Kristian Cibulskis; Carrie Sougnez; Friedhelm Hildebrandt; Edgar A Otto; Susanne Held; Bill H Diplas; Erica E Davis; Mario Mikula; Charles M Strom; Bruria Ben-Zeev; Dorit Lev; Tally Lerman Sagie; Marina Michelson; Yuval Yaron; Amanda Krause; Eugen Boltshauser; Nadia Elkhartoufi; Joelle Roume; Stavit Shalev; Arnold Munnich; Sophie Saunier; Chris Inglehearn; Ali Saad; Adila Alkindy; Sophie Thomas; Michel Vekemans; Bruno Dallapiccola; Nicholas Katsanis; Colin A Johnson; Tania Attié-Bitach; Joseph G Gleeson Journal: Nat Genet Date: 2010-05-30 Impact factor: 38.330
Authors: Francesc R Garcia-Gonzalo; Siew C Phua; Elle C Roberson; Galo Garcia; Monika Abedin; Stéphane Schurmans; Takanari Inoue; Jeremy F Reiter Journal: Dev Cell Date: 2015-08-24 Impact factor: 12.270
Authors: Julie C Van De Weghe; Tamara D S Rusterholz; Brooke Latour; Megan E Grout; Kimberly A Aldinger; Ranad Shaheen; Jennifer C Dempsey; Sateesh Maddirevula; Yong-Han H Cheng; Ian G Phelps; Matthias Gesemann; Himanshu Goel; Ohad S Birk; Talal Alanzi; Rifaat Rawashdeh; Arif O Khan; Michael J Bamshad; Deborah A Nickerson; Stephan C F Neuhauss; William B Dobyns; Fowzan S Alkuraya; Ronald Roepman; Ruxandra Bachmann-Gagescu; Dan Doherty Journal: Am J Hum Genet Date: 2017-06-15 Impact factor: 11.025
Authors: Brooke L Latour; Julie C Van De Weghe; Tamara Ds Rusterholz; Stef Jf Letteboer; Arianna Gomez; Ranad Shaheen; Matthias Gesemann; Arezou Karamzade; Mostafa Asadollahi; Miguel Barroso-Gil; Manali Chitre; Megan E Grout; Jeroen van Reeuwijk; Sylvia Ec van Beersum; Caitlin V Miller; Jennifer C Dempsey; Heba Morsy; Michael J Bamshad; Deborah A Nickerson; Stephan Cf Neuhauss; Karsten Boldt; Marius Ueffing; Mohammad Keramatipour; John A Sayer; Fowzan S Alkuraya; Ruxandra Bachmann-Gagescu; Ronald Roepman; Dan Doherty Journal: J Clin Invest Date: 2020-08-03 Impact factor: 14.808
Authors: Marijn F Stokman; Kirsten Y Renkema; Rachel H Giles; Franz Schaefer; Nine V A M Knoers; Albertien M van Eerde Journal: Nat Rev Nephrol Date: 2016-07-04 Impact factor: 28.314
Authors: Kenneth B Schou; Johanne B Mogensen; Stine K Morthorst; Brian S Nielsen; Aiste Aleliunaite; Andrea Serra-Marques; Nicoline Fürstenberg; Sophie Saunier; Albane A Bizet; Iben R Veland; Anna Akhmanova; Søren T Christensen; Lotte B Pedersen Journal: Nat Commun Date: 2017-01-30 Impact factor: 14.919
Authors: Brian P Brooks; Wadih M Zein; Amy H Thompson; Maryam Mokhtarzadeh; Daniel A Doherty; Melissa Parisi; Ian A Glass; May C Malicdan; Thierry Vilboux; Meghana Vemulapalli; James C Mullikin; William A Gahl; Meral Gunay-Aygun Journal: Ophthalmology Date: 2018-07-25 Impact factor: 12.079
Authors: Metta B Pratt; Joshua S Titlow; Ilan Davis; Amy R Barker; Helen R Dawe; Jordan W Raff; Helio Roque Journal: J Cell Sci Date: 2016-08-30 Impact factor: 5.285